Related Experiment Video

Updated: Sep 24, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

[Anti-aggregating agents: for which patients?]

G Nicolas

    Annales De Cardiologie Et D'Angeiologie
    |December 1, 1986
    PubMed

    Insights

    Anti-platelet medications are crucial for preventing thrombus formation and managing cardiac conditions like unstable angina and myocardial infarction. Moderate aspirin dosage is currently favored for optimal outcomes in cardiac pathology.

    Area of Science:

    • Cardiology and Thrombosis
    • Pharmacology

    Context:

    • Platelets play a central role in thrombus formation and atheromatous plaque development.
    • Anti-platelet medications are of significant interest in managing cardiac pathology.

    Purpose:

    • To evaluate the role and efficacy of anti-platelet medications in cardiac pathology.
    • To provide guidance on the prescription and dosage of anti-platelet therapy.

    Summary:

    • Anti-platelet therapy is indicated in situations with a risk of thrombus formation or extension.
    • Recent trials demonstrate benefits in unstable angina, aorto-coronary bypass, and secondary prevention of myocardial infarction.
    • Early initiation of treatment is recommended for cardiac surgery, with a trend towards moderate aspirin dosage.

    Impact:

    • Supports the legitimate use of anti-platelet medications in various cardiac conditions.
    • Informs clinical practice regarding the timing and dosage of anti-platelet therapy.
    • Highlights the importance of anti-platelet agents in cardiovascular disease management.

    More Related Videos

    Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study11:10

    Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

    Published on: June 29, 2016

    Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay07:52

    Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

    Published on: September 10, 2018

    Related Concept Videos

    Antibody Structure01:10

    Antibody Structure

    Overview
    Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
    The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
    Antibodies consist of four polypeptide chains: two identical heavy...
    Affinity and Avidity01:41

    Affinity and Avidity

    Overview
    Cross-reactivity00:42

    Cross-reactivity

    Overview
    Hybridoma Technology01:31

    Hybridoma Technology

    Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
    Hybridoma Selection
    Commonly used fusion techniques — electroporation, polyethylene glycol...
    Antibody Structure and Classes01:25

    Antibody Structure and Classes

    Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
    The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
    Antibody Actions01:26

    Antibody Actions

    Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
    Neutralization
    Antibodies can bind to pathogens, preventing them from infecting host cells. This process...